WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today announced its participation in the following upcoming conferences:
• BMO Capital Markets – Boston Biotech Corporate Access Day on Tuesday, July 29th at the Boston Harbor Hotel in Boston, Massachusetts
Help employers find you! Check out all the jobs and post your resume.
